<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2182-5173</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Medicina Geral e Familiar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Med Geral Fam]]></abbrev-journal-title>
<issn>2182-5173</issn>
<publisher>
<publisher-name><![CDATA[Associação Portuguesa de Medicina Geral e Familiar]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2182-51732023000300248</article-id>
<article-id pub-id-type="doi">10.32385/rpmgf.v39i3.13607</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Terapêutica farmacológica inalada da DPOC nos cuidados de saúde primários: uma visão integrada]]></article-title>
<article-title xml:lang="en"><![CDATA[COPD inhaled drug therapy in primary health care: an integrated view]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[Rodrigo P.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[Rui]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,USF Garcia de Orta  ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Sãvida Medicina Apoiada, SA  ]]></institution>
<addr-line><![CDATA[Lisboa ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<volume>39</volume>
<numero>3</numero>
<fpage>248</fpage>
<lpage>255</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2182-51732023000300248&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2182-51732023000300248&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2182-51732023000300248&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo A DPOC é uma doença crónica incapacitante e caracterizada por sintomas respiratórios persistentes e por limitação do fluxo aéreo. Está frequentemente associada a múltiplas comorbilidades que devem ser geridas de forma integrada. A terapêutica inalatória é a terapêutica de eleição no tratamento dos doentes com DPOC. Quando se opta pela monoterapia, os anticolinérgicos de longa duração de ação devem ser privilegiados. A dupla broncodilatação é o tratamento basilar mais adequado para a maioria das pessoas com DPOC. A terapêutica tripla é necessária para uma subpopulação destes doentes, devendo o médico de família estar capacitado para a sua prescrição. O ensino e a avaliação regular da técnica inalatória são fundamentais para o sucesso terapêutico. Sugere-se a adoção do acrónimo EDUCAR (Explicar, Demonstrar, Usar, Corrigir, Anotar, Reavaliar) a ser aplicado em todas as oportunidades de consulta das pessoas sob terapêutica inalada, de forma a conseguir o maior benefício para o doente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract COPD is a chronic disabling disease with persistent respiratory symptoms and airflow limitation. It is frequently related to comorbidities that must be managed in an integrated way. Inhalation therapy is the therapy of choice for the treatment of COPD patients. When monotherapy is chosen, long-acting anticholinergics should be preferred. Dual bronchodilation is the most appropriate baseline treatment for most patients with COPD. Triple therapy is required for a subpopulation of these patients, and general practitioners/family doctors must be qualified to prescribe it. Teaching and regular assessment of inhalation techniques are key to therapeutic success. The adoption of the acronym EDUCAR (Explain, Demonstrate, Use, Correct, Annotate, Reassess) is proposed to be applied in all appointments of people using inhaled therapy to achieve the greatest benefit for the patient.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[DPOC]]></kwd>
<kwd lng="pt"><![CDATA[Inaladores]]></kwd>
<kwd lng="pt"><![CDATA[Broncodilatadores]]></kwd>
<kwd lng="pt"><![CDATA[Agudização]]></kwd>
<kwd lng="pt"><![CDATA[Função pulmonar]]></kwd>
<kwd lng="en"><![CDATA[COPD]]></kwd>
<kwd lng="en"><![CDATA[Inhalers]]></kwd>
<kwd lng="en"><![CDATA[Bronchodilators]]></kwd>
<kwd lng="en"><![CDATA[Exacerbation]]></kwd>
<kwd lng="en"><![CDATA[Lung function]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Gold Initiative for Chronic Obstructive Lung Disease</collab>
<source><![CDATA[Golden strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 report)]]></source>
<year>2023</year>
<publisher-name><![CDATA[GOLD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Usmani]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
<name>
<surname><![CDATA[Capstick]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Saleem]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Scullion]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD]]></source>
<year>2020</year>
<publisher-name><![CDATA[UK Guidelines]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>National Asthma Council Australia</collab>
<source><![CDATA[Inhaler technique in people with asthma or COPD]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Melbourne ]]></publisher-loc>
<publisher-name><![CDATA[National Asthma Council Australia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Usmani]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Choosing the right inhaler for your asthma or COPD patient]]></article-title>
<source><![CDATA[Ther Clin Risk Manag]]></source>
<year>2019</year>
<volume>15</volume>
<page-range>461-72</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahler]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2020</year>
<volume>161</volume>
<page-range>105857</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Guia prático de gestão da DPOC nos cuidados de saúde primários]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Springer Healthcare Ibérica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>The Management of Chronic Obstructive Pulmonary Disease Work Group</collab>
<source><![CDATA[VA/DoD Clinical practice guideline for the management of chronic obstructive pulmonary disease: version 3]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Department of Veterans Affairs ]]></publisher-loc>
<publisher-name><![CDATA[Department of Defense]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nici]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mammen]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Charbek]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Au]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacologic management of chronic obstructive pulmonary disease an official American Thoracic Society clinical practice guideline]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2020</year>
<volume>201</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>e56-69</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Donohue]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Boucot]]></surname>
<given-names><![CDATA[IH]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Compton]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Future concepts in bronchodilation for COPD dual-versus monothe-rapy]]></article-title>
<source><![CDATA[Eur Respir Rev]]></source>
<year>2021</year>
<volume>30</volume>
<numero>160</numero>
<issue>160</issue>
<page-range>210023</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mammen]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pai]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Aaron]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Nici]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Alhazzani]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dual LABA/LAMA therapy versus LABA or LAMA monotherapy for chronic obstructive pulmonary disease a systematic review and meta-analysis in support of the American thoracic society clinical practice guideline]]></article-title>
<source><![CDATA[Ann Am Thorac Soc]]></source>
<year>2020</year>
<volume>17</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1133-43</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bafadhel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pavord]]></surname>
<given-names><![CDATA[ID]]></given-names>
</name>
<name>
<surname><![CDATA[Russell]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eosinophils in COPD: just another biomarker?]]></article-title>
<source><![CDATA[Lancet Respir Med]]></source>
<year>2017</year>
<volume>5</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>747-59</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilkinson]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are inhaled corticosteroids increasing the 'load' for some patients with COPD]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2017</year>
<volume>50</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1701848</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stolz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The right treatment for the right patient with COPD lessons from the IMPACT trial]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2020</year>
<volume>55</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>2000881</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mammen]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lloyd]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Pai]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Kunadharaju]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Triple therapy versus dual or monotherapy with long-acting bronchodilators for chronic obstructive pulmonary disease a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Ann Am Thorac Soc]]></source>
<year>2020</year>
<volume>17</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1308-18</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Laska]]></surname>
<given-names><![CDATA[IF]]></given-names>
</name>
<name>
<surname><![CDATA[Franssen]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Janssens]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Pavord]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rigau]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Withdrawal of inhaled corticosteroids in COPD a European Respiratory Society guideline]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2020</year>
<volume>55</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2000351</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Micheletto]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Braido]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Contoli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Di Marco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Santus]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD a proposal for COPD management]]></article-title>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2019</year>
<volume>14</volume>
<page-range>2185-93</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Celli]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Cowans]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Crim]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hartley]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease a systematic review]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2021</year>
<volume>203</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>689-98</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[West]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Brusselle]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gruffydd-Jones]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of COPD in the UK primary-care setting an analysis of real-life prescribing patterns]]></article-title>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2014</year>
<volume>9</volume>
<page-range>889-904</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Quibrera]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Carretta]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Barr]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Bleecker]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Bowler]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency of exacerbations in patients with chronic obstructive pulmonary disease an analysis of the SPIROMICS cohort]]></article-title>
<source><![CDATA[Lancet Respir Med]]></source>
<year>2017</year>
<volume>5</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>619-26</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[MacLeod]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Papi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Contoli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Beghé]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Celli]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Wedzicha]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease exacerbation fundamentals diagnosis, treatment, prevention and disease impact]]></article-title>
<source><![CDATA[Respirology]]></source>
<year>2021</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>532-51</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
